A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE

Kidney International

Volumn 69, Issue 3, 2006, Pages 526-530

  Quintana, L F ^a   Guzman B ^a   Collado, S ^a   Claria J ^b   Poch, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

12 HETE; 12 lipoxygenase; Eicosanoids; Hypertension; Polymorphism

Indexed keywords

AMINO ACID; HYDROXYICOSATETRAENOIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC ANALYSIS; GENETIC CODE; GENETIC DISORDER; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; URINARY EXCRETION; URINE LEVEL;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ADULT; AGED; AGED, 80 AND OVER; ARACHIDONATE 12-LIPOXYGENASE; BLOOD PRESSURE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 31544454435     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000147     Document Type: Article

References (24)

1. Izumi T, Hoshiko S, Radmark O, Samuelsson B. Cloning of the cDNA for human 12-lipoxygenase. Proc Natl Acad Sci USA 1990; 87: 7477-7481.
2. Gonzalez-Nunez D, Sole M, Natarajan R, Poch E. 12-Lipoxygenase metabolism in mouse distal convoluted tubule cells. Kidney Int 2005; 67: 178-186.
3. +-ATPase in the cornea. Proc Natl Acad Sci USA 1987; 84: 8125-8129.
4. Krieg P, Siebert M, Kinzig A et al. Murine 12(R)-lipoxygenase: functional expression, genomic structure and chromosomal localization. FEBS Lett 1999; 446: 142-148.
5. Poch E. Role of lipoxygenase metabolites in cardiovascular disease. Curr Hypertens Rep 2003; 5: 1-2.
6. Ma YH, Harder DR, Clark JE, Roman RJ. Effects of 12-HETE on isolated dog renal arcuate arteries. Am J Physiol 1991; 261: H451-H456.
7. Nadler JL, Natarajan R, Stern N. Specific action of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone synthesis in isolated adrenal glomerulosa cells. J Clin Invest 1987; 80: 1763-1769.
8. Saito F, Hori MT, Ideguchi Y et al. 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells. Hypertension 1992; 20: 138-143.
9. Nozawa K, Tuck ML, Golub M et al. Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am J Physiol 1990; 259: H1774-H1780.
10. Stern N, Kisch ES, Knoll E. Platelet lipoxygenase in spontaneously hypertensive rats. Hypertension 1996; 27: 1149-1152.
11. Stern N, Nozawa K, Golub M et al. The lipoxygenase inhibitor phenidone is a potent hypotensive agent in the spontaneously hypertensive rat. Am J Hypertens 1993; 6: 52-58.
12. Gonzalez-Nunez D, Claria J, Rivera F, Poch E. Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension 2001; 37: 334-338.
13. McGiff JC, Carroll MA, Escalante B. Arachidonate metabolites and kinins in blood pressure regulation. Hypertension 1991; 18: III150-III157.
14. Setty BN, Stuart MJ. 15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease. J Clin Invest 1986; 77: 202-211.
15. Rahman M, Wright Jr JT, Douglas JG. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review. Am J Hypertens 1997; 10: 356-365.
16. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82: 131-185.
17. Gainer JV, Bellamine A, Dawson EP et al. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 2005; 111: 63-69.
18. Stern N, Golub M, Nozawa K et al. Selective inhibition of angiotensin 11-mediated vasoconstriction by lipoxygenase blockade. Am J Physiol 1989; 257: H434-H443.
19. Sasaki M, Hori MT, Hino T et al. Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat. Am J Hypertens 1997; 10: 371-378.
20. Antonipillai I, Nadler J, Vu EJ et al. A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease. J Clin Endocrinol Metab 1996; 81: 1940-1945.
21. Kang SW, Adler SG, Nast CC et al. 12-Lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy. Kidney Int 2001; 59: 1354-1362.
22. Clouet P, Niot I, Bouchard P et al. Distribution of tritium labeled 12(5) hydroxy-eicosatetraenoic acid (12-HETE) in the rat. Prostaglandins 1991; 42: 39-45.
23. Cyrus T, Witztum JL, Rader DJ et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999; 103: 1597-1604.
24. Gu JL, Pei H, Thomas L et al. Ribozyme-mediated inhibition of rat leukocyte-type 12-lipoxygenase prevents intimai hyperplasia in balloon-injured rat carotid arteries. Circulation 2001; 103: 1446-1452.